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The catalytic enantioselective synthesis of a range of cis-pyrrolizine carboxylate derivatives with outstand-
ing stereocontrol (14 examples, >95 : 5 dr, >98 : 2 er) through an isothiourea-catalyzed intramolecular
Michael addition-lactonisation and ring-opening approach from the corresponding enone acid is
reported. An optimised and straightforward three-step synthetic route to the enone acid starting materials
from readily available pyrrole-2-carboxaldehydes is delineated, with benzotetramisole (5 mol%) proving
the optimal catalyst for the enantioselective process. Ring-opening of the pyrrolizine dihydropyranone
products with either MeOH or a range of amines leads to the desired products in excellent yield and
enantioselectivity. Computation has been used to probe the factors leading to high stereocontrol, with
the formation of the observed cis-steroisomer predicted to be kinetically and thermodynamically
favoured.
Introduction
The 5,5-bicyclic pyrrolizine and pyrrolizidine structural motifs
that contain a bridgehead nitrogen atom are present within
the core of many biologically active natural products1 such as
that of dehydroretronecine 1 (Fig. 1).2 This natural product,
along with many other derivatives, originates from metabolism
of pyrrolizidine alkaloids (PAs), a natural alkaloid prevalent in
plant life throughout nature.3 Such PA-derived molecules are
known to be potent heptatoxins,4 carcinogens,5 teratogens6
and genotoxins.7 Compelled by such levels of biological
activity, many of these natural products and their derivatives
have become commercial therapeutic agents. For example, the
partially reduced pyrrolizine mitomycin C 2, isolated from
Streptomyces caespitosus or Streptomyces lavendulae, is a potent
antitumour drug with a broad scope of applications.8 The non-
steroidal anti-inflammatory drug (NSAID), Licofelone 3 has
shown great promise in osteoarthritis treatment through a
dual inhibition of 5-LOX/COX.9 Additionally, another pyrrol-
izine based NSAID, Ketorolac 4, has found success as a com-
mercial analgesic.10
Given the value and potential of these bicyclic compounds,
a variety of synthetic routes towards these motifs have been
designed, with many syntheses involving classic total synthesis
approaches towards specific target molecules.11 In recent years
the state-of-the-art in catalytic pyrrolizine syntheses has
involved diastereoselective multi-step reaction processes such
Fig. 1 Representative biologically active pyrrolizines.
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as the phosphine-catalysed domino reaction developed by
Tong and co-workers13 (Fig. 2a) or the gold-catalysed process
by Matsuya and co-workers (Fig. 2b).14 Catalytic enantio-
selective methodologies that enable eﬃcient access to this
desirable structural motif are relatively limited. Within this
area, Cho and co-workers showed that an enantioselective
organocatalysed Michael addition-aldol approach could gene-
rate functionalised pyrrolizines with excellent diastereo- and
enantiocontrol (18 examples, >95 : 5 dr and 95 : 5 to 99 : 1 er,
Fig. 2c), although relatively high catalyst loadings were
employed to promote this process.15 In spite of these advances
there is still a clear requirement for easily accessible and
reliable catalytic methodologies that can produce stereo-
defined chiral pyrrolizine derivatives with high levels of
eﬃciency and enantiocontrol.
Following seminal work from Romo and co-workers using
ammonium enolates generated from carboxylic acids,16 our-
selves and others,17 have used isothioureas18 to catalyse a
range of formal [2 + 2],19 [3 + 2]20 and [4 + 2]21 cycloaddition
processes that employ an ammonium enolate intermediate.22
Related intramolecular Michael addition-lactonisation cas-
cades from enone-acid substrates have been used to generate
simple heterocyclic products such as THFs and pyrrolidines
with excellent enantioselectivity.23 Building upon this previous
work, the application of this strategy to construct the highly
desirable pyrrolizine core in a catalytic enantioselective
fashion starting from pyrrole-derived enone acid substrates
such as 5 is investigated (Fig. 3). At the onset of these studies
the main challenges were envisaged to arise from the incorpor-
ation of the electron-rich N-functionalised pyrrole core within
the target enone-acid. A robust method to access this struc-
tural motif has not been reported previously, while the eﬀect
of incorporating this planar electron-rich aromatic structure
upon stability and reactivity, as well as the conformational and
steric eﬀects upon diastereo- and enantioselectivity were
unknown. Furthermore, the potential for competitive intra-
molecular Friedel–Crafts acylation of the pyrrole via a mixed
anhydride or acyl ammonium ion intermediate,24 or alterna-
tively β-elimination from an ammonium enolate, needed to be
assessed. To further enhance our understanding of this
process, we also wanted to probe the course of the proposed
cascade cyclisation process via computation in order to under-
stand the factors leading to stereocontrol. Very limited compu-
tational analysis of the use of isothiourea-derived ammonium
enolates in catalysis has been reported.25 To date only the
single report from Muck-Lichtenfeld and Studer concerning
the intermolecular formal 1,3-dipolar cycloaddition of azo-
methine imines with mixed anhydrides under isothiourea cat-
alysis has incorporated DFT analysis.20a
In this manuscript we report the realisation of this strategy
to facilitate the catalytic enantioselective synthesis of these
valuable heterocyclic products 6 and 7. A straightforward
three-step synthetic route to the enone acid starting materials
from readily available pyrrole-2-carboxaldehydes is delineated,
with commercially available benzotetramisole (BTM) proving
the optimal catalyst for the enantioselective process. Further-
more, the use of computational analysis allows insight into
the origin of stereocontrol in this intramolecular cascade
process.
Fig. 2 Current catalytic methods for pyrrolizine synthesis.
Fig. 3 Proposed isothiourea-catalysed Michael addition-lactonisation
methodology for pyrrolizine synthesis.
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Initial studies set out to devise a practical synthetic route
towards the target pyrrole-derived enone-acid substrates. Sub-
strate 11 was identified as a model system, and was initially pre-
pared from pyrrole 2-carboxaldehyde by N-alkylation, ester
hydrolysis and Wittig olefination. However, attempted synthesis
of a range of pyrrole-derived enone-acid substrates or scale-up
of this synthetic route proved low yielding and irreproducible
when directed towards alternative substrates. After a thorough
investigation into alternative synthetic approaches, a reliable
three-step sequence starting from the corresponding pyrrole
2-carboxaldehyde was established (Scheme 1). Aldol-conden-
sation with the requisite ketone provides a general and chrom-
atography-free preparation of pyrrole-enones 8. Treatment with
sub-stoichiometric t-BuOK and methyl acrylate gives the N-alkyl-
ation product 9, with subsequent ester hydrolysis providing the
desired enone-acid substrates 10 in good overall yield with a
wide scope available. This reliable synthetic sequence allowed
the preparation of a range of substrates 11–18 in up to 58%
yield over three steps and on multigram scale, and allows for
substituent variation within both the pyrrole and enone com-
ponents.26 Direct chlorination of 11 with N-chlorosuccinimide
(NCS) led to substrate 19, while an analogous procedure using
acetone for the aldol reaction procedure, followed by alkylation
and ester hydrolysis gave methyl enone 20.
Reaction optimisation
With a reliable synthetic route to pyrrole-derived enone acid
substrates in hand, the feasibility and subsequent optimi-
sation of the isothiourea-catalysed Michael addition-lactonisa-
tion protocol was conducted (Table 1). Utilising achiral
isothiourea DHPB 22, i-Pr2NEt and t-BuCOCl provided the
desired pyrrolizine dihydropyranone 21 from enone-acid 11 in
a moderate 41% isolated yield but with excellent >95 : 5 dr
(entry 1). Alternative methods for in situ generation of a reac-
tive carboxylate derivative, such as Mukaiyama’s reagent 26,
did not improve conversion or isolated yield (entry 2). A signifi-
cant improvement in yield was observed when the equivalents
of both t-BuCOCl and i-Pr2NEt were increased from 1.5 to 3.0
equiv., with 21 obtained in 84% yield. Subsequent studies
assessed the feasibility of an enantioselective process, with
chiral isothiourea catalysts 23–25 examined. Tetramisole·HCl
23 and benzotetramisole (BTM) 24-mediated reactions (entries
4 and 5) provided 21 in excellent yield, >95 : 5 dr and with
>99 : 1 er. Application of HyperBTM 25 proved marginally less
eﬀective, with the product 21 obtained in high yield and dr
but with reduced 96.5 : 3.5 er (entry 6). Notably in all of these
catalytic processes no competitive products arising from either
Friedel–Crafts acylation or β-elimination were observed,
despite the proposed intermediacy of an acyl ammonium ion.
The eﬀect of reduced catalyst loading using BTM 24 and tetra-
misole·HCl 23 was next evaluated. Using 5 mol% BTM 24
maintained excellent levels of diastereo- and enantioselectivity,
giving product 21 in 82% yield, while using 5 mol% tetra-
Scheme 1 Optimised synthesis of pyrrole-derived enone-acid
substrates.








1 t-BuCOCl (1.5) 22 (10) 41 >95 : 5 —
2 26 (1.5) 22 (10) 45 >95 : 5 —
3 t-BuCOCl (3.0) 22 (10) 84 >95 : 5 —
4 t-BuCOCl (3.0) 23 (10) 84 >95 : 5 >99 : 1(ent )
5 t-BuCOCl (3.0) 24 (10) 81 >95 : 5 >99 : 1
6 t-BuCOCl (3.0) 25 (10) 81 >95 : 5 96.5 : 3.5
7 t-BuCOCl (3.0) 24 (5) 82 >95 : 5 >99 : 1
8 t-BuCOCl (3.0) 23 (5) 67 >95 : 5 >99 : 1(ent )
9 t-BuCOCl (3.0) 24 (1) 42 >95 : 5 >99 : 1
10 t-BuCOCl (3.0) 23 (1) 34 >95 : 5 99 : 1(ent )
a Applied in 1 : 1 ratio with i-Pr2NEt.
b Isolated yield. cDetermined by
1H NMR of the crude reaction product. dDetermined by chiral HPLC.
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misole·HCl 23 led to reduced but still acceptable 67% yield
(entries 7 and 8). Further reduction of the catalyst loading to
1 mol% showed the same trend in reactivity, with BTM-24
giving 21 in 42% isolated yield, and tetramisole·HCl 23 a lower
34% yield, yet still in high dr and er (entries 9 and 10). All
further studies used BTM 24 (5 mol%) as the optimal reaction
conditions for this enantioselective process.
As an alternative strategy to the isolation of dihydropyra-
none 21 in situ ring-opening with a suitable nucleophile was
investigated to provide access to pyrrolizine carboxylate deriva-
tives (Table 2). Taking pyrrole-derived enone-acid 11 under the
optimum catalysis conditions the resulting dihydropyranone
21 can be readily ring-opened in situ with MeOH giving
pyrrolizine methyl ester 27 in excellent 86% yield, >95 : 5 dr
and >99 : 1 er. Ring-opening using both primary and secondary
amines to give pyrrolizine amides also proved successful. For
example, use of allylamine provided 28 in 81% yield, >95 : 5 dr
and 98.5 : 1.5 er, while ring-opening with pyrrolidine gave pyr-
rolizine amide 29 in quantitative yield, >95 : 5 dr and >99 : 1 er.
Morpholine, N-Boc piperazine and tetrahydrothieno[3,2-c]pyri-
dine could also be utilised, giving the corresponding pyrrol-
izine amides 30–32 in good to excellent yield (60–75%), >95 : 5
dr and >99 : 1 er. Upon standing the pyrrolizine carboxylate
products proved considerably more stable to storage than the
dihydropyranone 21, therefore ring-opening with MeOH was
used as the general procedure when exploring further substrate
scope.
Substrate scope: Michael addition-lactonisation/methanolysis
With a reliable synthetic route to pyrrole-derived enone acid
substrates available, the generality of the isothiourea catalysis
using BTM 24 as the catalyst and MeOH as the nucleophile for
in situ ring-opening was evaluated (Table 3). Variation of the
enone-substituent of the substrate was first investigated with a
range of aryl groups accommodated. Brominated aryl units
Table 2 Michael addition-lactonisation/ring-opening protocola,b,c
a Isolated yield. b dr determined by 1H NMR of the crude reaction
product. c er determined by chiral HPLC.
Table 3 Michael addition-lactonisation/methanolysis scope: variation
of Michael acceptora,b,c
a Isolated yield. b dr determined by 1H NMR of the crude reaction
product. c er determined by chiral HPLC.
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can be included to give 33 and 34 in 78% and 74% yield,
respectively, with both generated as single diastereoisomers in
>99 : 1 er. Incorporation of the heterocyclic 2-thienyl substitu-
ent was readily tolerated giving 35 in 77% yield, >95 : 5 dr and
99 : 1 er. Electron-rich groups (4-MeOC6H4) can be installed,
giving 36 in excellent 93% yield, >95 : 5 dr and >99 : 1 er.
Both 1-naphthyl and 2-naphthyl units can also be incorpor-
ated to access the corresponding products 37 and 38 in good
yields and excellent enantioselectivity, although attempted cat-
alysis using Me-enone 20 did not result in any conversion to
product. Variation within the pyrrole core of the pyrrolizine
carboxylate product was also assessed. Chlorinated product 39
was produced in 66% yield with good 94 : 6 dr and as a single
enantiomer (>99 : 1 er). The core motif can be expanded to the
hexahydro-1H-pyrroloindole structure with the corresponding
product 40 achieved in 53% yield and excellent stereo-
selectivity (>95 : 5 dr and >99 : 1 er).27 The reaction to form 33
was readily carried out on a 1 gram scale, giving the desired
product in 67% yield in >95 : 5 dr and >99 : 1 er. The relative
and absolute configuration within 33 was assigned by X-ray
crystallography analysis, with the configuration within all
other products assigned by analogy (Fig. 4).28
Product derivatisation
To exemplify that this methodology can potentially be used as
a basis for further synthetic elaboration, product derivatisation
within both the pyrrole core and aromatic ketone substituent
was explored (Scheme 2). For example, the synthesis of
product 33 using this cascade methodology gives a product
with the bromine functional handle. Through the use of a
Suzuki–Miyaura coupling 33 was readily elaborated to access
the polyheteroaromatic pyrrolizine 41 in 60% isolated yield
and with no loss of stereointegrity. Alternatively, a simple
chlorination of the pyrrole core within 27 was conducted using
NCS to access chloropyrrolizine 42 in 79% yield.
Proposed mechanism and computational studies
A proposed catalytic cycle for the synthesis of pyrrolizine
dihydropyranone 21 from enone-acid 11 is shown in Scheme 3.
Firstly, pivaloyl chloride reacts with the enone-acid to form
mixed anhydride 43, with subsequent nucleophilic attack from
the Lewis base catalyst BTM 24 generating acyl ammonium ion
44. Deprotonation to form (Z)-ammonium enolate 45, followed
by intramolecular Michael-addition forms the new C–C bond
and two stereocentres in the initial cyclisation step. Intermedi-
ate 45 is believed to be stabilised by a favourable non-bonding
or electrostatic O to S interaction and this has been investi-
gated computationally (vide infra). Subsequent lactonisation
releases catalyst 24 and the polycyclic dihydropyranone
product 21, which can be ring-opened upon addition of a
nucleophilic amine or alcohol to give the isolated pyrrolizine
carboxylate derivative.
Fig. 4 Molecular representation of the X-ray structure of 33.
Scheme 2 Product derivatisation.
Scheme 3 Proposed mechanism of isothiourea-catalysed Michael
addition-lactonisation.
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On the basis of this mechanistic hypothesis, the origin of
the diastereo- and enantioselective formation of the pyrrol-
izine dihydropyranone products in this BTM 24-catalysed
cascade process was further probed through density func-
tional theory (DFT) calculations. Calculations employed the
M06-2X functional and investigated the cyclisation of the
parent enone-acid 21 reacting in the presence of 24 in di-
chloromethane solvent from either the (E)- or (Z)-form of the
ammonium enolate. Full computational details, including
results obtained with the B3LYP functional, are supplied in
the ESI.†29
Fig. 5 shows computed profiles for the alternative reactions
of the (Z)-ammonium enolate, (Z)-45, to form the cis- and
trans-isomers of pyrrolizine dihydropyranone 21. From (Z)-45
two low energy transition states were located for the Michael
cyclisation step: TS1cis at +5.2 kcal mol
−1 and TS1trans at
+10.0 kcal mol−1. The onward reaction via TS1cis (highlighted
in red) leads to 46cis at −0.6 kcal mol−1 in which the newly
formed C4–C9 bond is rather long at 1.62 Å. Attack of the
enolate oxygen then permits formation of a zwitterionic tetra-
hedral dihydropyran intermediate 47cis via TS2cis at +6.3
kcal mol−1. Facile dissociation of BTM 24 from 47cis via TS3cis
forms 21cis at −18.2 kcal mol−1. An analogous series of steps
(highlighted in blue) was also characterized for the formation
of 21trans at −13.0 kcal mol−1. Formation of 21cis is therefore
both thermodynamically and kinetically favoured, as both
TS1cis and TS2cis are significantly lower than TS1trans en route
to 21trans. A third pathway starting from the (E)-ammonium
enolate precursor, (E)-45 (+3.7 kcal mol−1) and leading to the
enantiomeric-trans product was also characterised, but has a
significantly higher barrier of 16.7 kcal mol−1 and can there-
fore be discounted (see ESI†).
It is notable that all the computed structures for both reac-
tion pathways in Fig. 5 from enolate (Z)-45 up to the final BTM
dissociation steps feature a co-planar [1,5]-S⋯O motif with
[1,5]-S⋯O interatom distances ranging from 2.60 Å to 2.82 Å.
The importance of non-bonding S⋯O interactions has been
widely recognized in structural and medicinal chemistry in the
solid state (often described as a stabilising nO to σ*CS inter-
action),30 and has been previously recognised as a controlling
element in enantioselective isothiourea-catalyzed reaction pro-
cesses.31 Although the origin of this interaction is still under
debate,32 in all calculated structures the [1,5]-S⋯O distance is
considerably below the sum of the van der Waals radii. Inter-
estingly, the shortest distances calculated are found within
(Z)-45 (2.64 Å) and zwitterionic intermediates (47cis 2.60 Å and
47trans 2.64 Å), presumably reflecting the formal negative
charge on the oxygen atom within these structures. However,
as this feature appears within all the structures in the com-
puted reaction profiles, and varies in a similar way along those
profiles, it does not appear to be a discriminating factor
between the two pathways in Fig. 5.
Computed structures for the selectivity-determining tran-
sition states TS1cis and TS1trans are compared in Fig. 6. Both
structures have similar distances (2.09 and 2.10 Å) for the
forming C4⋯C9 bond, with Michael addition occurring anti-to
the stereodirecting phenyl substituent and thus accounting for
the observed enantioselectivity. In the favoured TS1cis arrange-
ment the prostereogenic centres adopt an approximately
eclipsed conformation with a H–C4⋯C9–H dihedral of 3°,
Fig. 5 Computed free energy proﬁles (M06-2X(CH2Cl2), kcal mol
−1) for the formation of cis- and trans-pyrrolizine dihydropyranones 21 from
(Z)-ammonium enolate (Z)-45.
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while in TS1trans the corresponding H–C4⋯C9–H dihedral is
149.5°. Both transition states also exhibit short and approxi-
mately co-planar [1,5]-S⋯O1 contacts of ca. 2.7 Å between the
BTM sulfur atom and the enolate oxygen. The near-parallel
arrangement of the BTM moiety and the enone aryl substitu-
ent in TS1cis (inter-plane angle = 5.7°) appears set up for stabi-
lising π-stacking interactions that should be captured by the
M06-2X functional.29 Indeed with the B3LYP functional (where
such dispersion eﬀects are not treated) the equivalent inter-
plane angle = 28.1° and the preference for TS1cis is reduced to
only 1.4 kcal mol−1 (see ESI†). Also noticeable in TS1cis are two
short contacts between the forming oxy-anion on the enone
(O2) and two C–H hydrogens upon the positively charged iso-
thiouronium core (O1⋯H1 2.19 Å and O1⋯H2 2.37 Å). The
enhanced acidity of these hydrogen atoms may facilitate some
non-classical H-bonding and so confer greater stability on
TS1cis over TS1trans where the analogous contacts are distinctly
longer (O1⋯H1 2.72 Å and O1⋯H2 2.65 Å). While not particu-
larly strong individually, these various eﬀects likely combine to
stabilise TS1cis over TS1trans and so account for the observed
selectivity for the cis product.
Conclusions
In conclusion, an optimised and straightforward three-step
synthetic route to a range of pyrrole-derived enone acid start-
ing materials from readily available pyrrole-2-carboxaldehydes
is delineated. The catalytic enantioselective synthesis of a
range of cis-pyrrolizine carboxylate derivatives proceeds with
outstanding stereocontrol (14 examples, >95 : 5 dr, >98 : 2 er)
with benzotetramisole proving the optimal catalyst for this
process. In situ ring-opening of the pyrrolizine dihydropyra-
none products with either MeOH or a range of amines leads to
the desired products in excellent yield and enantioselectivity.
Computation has been used to probe the factors leading to
high stereocontrol in this reaction process, with the formation
of the observed cis-stereoisomer predicted to be both kineti-
cally and thermodynamically favoured. Further work from this
laboratory will utilise this methodology for the synthesis of
target molecules and probe the utility of isothioureas and
other Lewis bases in enantioselective catalysis.
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